Johns Hopkins Antibiotic Guide is a clinical reference app for medical professionals, providing evidence-based antimicrobial, HIV, diabetes, and psychiatry guidelines on iOS and Android.
Product velocity
Maintenance
Daily rank 🇺🇸
#23
Medical · grossing
Sentiment
4.8
5k reviews
Nemesis
AMBOSS Medical Knowledge
The App DNA
What makes this app unique?
Clinicians hire this app to access verified, expert-curated medical data at the point of care, reducing the risk of diagnostic or dosing errors during hospital shifts.
For Clinicians and medical professionals requiring evidence-based, frequently updated decision support at the point of care.
What does it look like?
Key features
Curated antimicrobial, HIV, diabetes, and psychiatry clinical references updated monthly by Johns Hopkins experts
Clinical application, safety, and ethical protocols for psychedelic medicine added to the psychiatry module
Enhanced search functionality for rapid access to drug interactions, dosing, and differential diagnoses
How much does it cost?
Subscription model anchored at $29.99 per guide, with a bundle discount to drive higher average revenue per user.
Velocity
Maintenance developmentmonetizationperformanceShow more...
The app exhibits a maintenance-level cadence, with only 4 releases identified over the last 8 months, averaging approximately 0.12 releases per week. Development is currently focused exclusively on payment infrastructure and subscription management, with no evidence of new content or feature expansion. The latest release on both Android and iOS platforms was limited to technical improvements for the purchase process. The development trend is stable but strictly focused on maintenance rather than growth.
Who built it?
Unbound Medicine
13+ apps tracked · Medical
User Sentiment
What do users think recently?
Recent user voice shows a mixed sentiment. Users appreciate comprehensive antibiotic reference content provides essential clinical support for hospitalists and infectious disease specialists, but report restrictive device management policies block access for users switching between multiple mobile phones.
How are ratings & reviews evolving?
What users say, by theme
- Comprehensive antibiotic reference content provides essential clinical support for hospitalists and infectious disease specialists
- Restrictive device management policies block access for users switching between multiple mobile phones
60 of 100 recent reviews analyzed · high confidence · Mixed overall
Read the full review analysisUnlock 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Johns Hopkins Antibiotic Guide
How's the Medical market?
The rivals identified
By AMBOSS
AMBOSS serves the exact same professional medical audience with a comprehensive, evidence-based knowledge platform that directly competes with the Johns Hopkins Guide's clinical decision support utility.
- Integrates interactive Q&A and study modes that drive daily engagement beyond simple reference lookups.
- Provides a unified cross-platform experience that bridges clinical practice with medical education and board preparation.
- Maintains a high-velocity content update cycle that keeps clinical guidelines current with emerging medical literature.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for Johns Hopkins Antibiotic Guide
Where is it heading?
The clinical reference market is consolidating around platforms that offer integrated educational and AI-driven synthesis, leaving static guides like this one exposed to churn. The app's future depends on transitioning from a single-device reference tool to a multi-device, AI-augmented clinical assistant to match the utility of modern rivals.
- Restrictive device-locking policies continue to drive negative sentiment, which compounds the churn risk among professional users who rely on multiple devices.
- The latest update to the psychiatry guide shows active content investment, ensuring the app remains a primary reference for specialized clinical practitioners.
The SWOT
- Brand authority of Johns Hopkins content sustains high-trust clinical adoption
- Monthly content update cadence maintains relevance in fast-moving infectious disease fields
- Point-of-care search utility minimizes cognitive load for hospitalists
- Expansion into wearable-integrated clinical alerts
- B2B partnerships with hospital systems for enterprise-wide access
- AI-driven natural language query integration to compete with OpenEvidence
Next best moves
Enable multi-device account syncing because device-locking is the top churn driver → improve retention
+ 1 more prioritized moveThe counter-intuitive read
The app's restrictive device-locking policy is not a…
Read the full takeFeature gaps
Interactive Q&A and study modes (available in AMBOSS) +2
Since the last report: The app's competitive position is declining due to restrictive device-locking policies and a reduced trial period, despite maintaining high-quality clinical content.
Bottom line
The app maintains high utility as a clinical reference, but its reputation is damaged by restrictive device-locking and opaque billing, so the PM must prioritize account-syncing and billing transparency to defend the core user base.
Unlock 3 critical frictions, 3 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated